Cargando…
Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386688/ https://www.ncbi.nlm.nih.gov/pubmed/37516861 http://dx.doi.org/10.1186/s13075-023-03117-4 |
| _version_ | 1785081729367670784 |
|---|---|
| author | Cutolo, Maurizio Gotelli, Emanuele Montagna, Paola Tardito, Samuele Paolino, Sabrina Pizzorni, Carmen Sulli, Alberto Smith, Vanessa Soldano, Stefano |
| author_facet | Cutolo, Maurizio Gotelli, Emanuele Montagna, Paola Tardito, Samuele Paolino, Sabrina Pizzorni, Carmen Sulli, Alberto Smith, Vanessa Soldano, Stefano |
| author_sort | Cutolo, Maurizio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10386688 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103866882023-07-30 Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity Cutolo, Maurizio Gotelli, Emanuele Montagna, Paola Tardito, Samuele Paolino, Sabrina Pizzorni, Carmen Sulli, Alberto Smith, Vanessa Soldano, Stefano Arthritis Res Ther Correction BioMed Central 2023-07-29 2023 /pmc/articles/PMC10386688/ /pubmed/37516861 http://dx.doi.org/10.1186/s13075-023-03117-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Cutolo, Maurizio Gotelli, Emanuele Montagna, Paola Tardito, Samuele Paolino, Sabrina Pizzorni, Carmen Sulli, Alberto Smith, Vanessa Soldano, Stefano Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity |
| title | Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity |
| title_full | Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity |
| title_fullStr | Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity |
| title_full_unstemmed | Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity |
| title_short | Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity |
| title_sort | correction: nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386688/ https://www.ncbi.nlm.nih.gov/pubmed/37516861 http://dx.doi.org/10.1186/s13075-023-03117-4 |
| work_keys_str_mv | AT cutolomaurizio correctionnintedanibdownregulatesthetransitionofculturedsystemicsclerosisfibrocytesintomyofibroblastsandtheirprofibroticactivity AT gotelliemanuele correctionnintedanibdownregulatesthetransitionofculturedsystemicsclerosisfibrocytesintomyofibroblastsandtheirprofibroticactivity AT montagnapaola correctionnintedanibdownregulatesthetransitionofculturedsystemicsclerosisfibrocytesintomyofibroblastsandtheirprofibroticactivity AT tarditosamuele correctionnintedanibdownregulatesthetransitionofculturedsystemicsclerosisfibrocytesintomyofibroblastsandtheirprofibroticactivity AT paolinosabrina correctionnintedanibdownregulatesthetransitionofculturedsystemicsclerosisfibrocytesintomyofibroblastsandtheirprofibroticactivity AT pizzornicarmen correctionnintedanibdownregulatesthetransitionofculturedsystemicsclerosisfibrocytesintomyofibroblastsandtheirprofibroticactivity AT sullialberto correctionnintedanibdownregulatesthetransitionofculturedsystemicsclerosisfibrocytesintomyofibroblastsandtheirprofibroticactivity AT smithvanessa correctionnintedanibdownregulatesthetransitionofculturedsystemicsclerosisfibrocytesintomyofibroblastsandtheirprofibroticactivity AT soldanostefano correctionnintedanibdownregulatesthetransitionofculturedsystemicsclerosisfibrocytesintomyofibroblastsandtheirprofibroticactivity |